Krebs MG, Delord JP, Jeffry Evans TR, De Jonge M, et al. Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study. Lung Cancer 2023;180:107216.
PMID: 37146473